Authors:
Bramson, HN
Corona, J
Davis, ST
Dickerson, SH
Edelstein, M
Frye, SV
Gampe, RT
Harris, PA
Hassell, A
Holmes, WD
Hunter, RN
Lackey, KE
Lovejoy, B
Luzzio, MJ
Montana, V
Rocque, WJ
Rusnak, D
Shewchuk, L
Veal, JM
Walker, DH
Kuyper, LF
Citation: Hn. Bramson et al., Oxindole-based inhibitors of cyclin-dependent kinase 2 (CDK2): Design, synthesis, enzymatic activities, and X-ray crystallographic analysis, J MED CHEM, 44(25), 2001, pp. 4339-4358
Authors:
Shewchuk, L
Hassell, A
Wisely, B
Rocque, W
Holmes, W
Veal, J
Kuyper, LF
Citation: L. Shewchuk et al., Binding mode of the 4-anilinoquinazoline class of protein kinase inhibitor: X-ray crystallographic studies of 4-anilinoquinazolines bound to cyclin-dependent kinase 2 and p38 kinase, J MED CHEM, 43(1), 2000, pp. 133-138
Authors:
Pesco-Koplowitz, L
Hassell, A
Lee, P
Zhou, HH
Hall, N
Wiesinger, B
Mechlinski, W
Grover, M
Hunt, T
Smith, R
Travers, S
Citation: L. Pesco-koplowitz et al., Lack of effect of erythromycin and ketoconazole on the pharmacokinetics and pharmacodynamics of steady-state intranasal levocabastine, J CLIN PHAR, 39(1), 1999, pp. 76-85